Thrixen
About:
Diagnotics, IVD, Point of Care,
Website: http://www.thrixen.com
Top Investors: 22Health Ventures, John Ballantyne
Description:
Thrixen is a biotech/Medtech company that aims to revolutionise the diagnostic technology for the detection of biomarkers at the chemistry level to unlock the next generation of diagnostic and health care monitoring tools that are simple and accessible at the point of care/need.
Total Funding Amount:
$7M
Headquarters Location:
Singapore, Central Region, Singapore
Founded Date:
2021-01-01
Contact Email:
info(AT)thrixen.com
Founders:
Hadley Sikes (Prof), Huan (Emma) Jia, Megan McBee (PhD), Patthara Kongsuphol (P.hd), Peter Preiser (Prof), Shavit Clein
Number of Employees:
1-10
Last Funding Date:
2024-04-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai